Patients benefiting from federally qualified health centers tend to be sicker than the general population, but there are also disparities by state, explained M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine.
Patients benefiting from federally qualified health centers tend to be sicker than the general population, but there are also disparities by state, explained M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine.
Transcript
How does the health of the population using federally qualified health centers differ from the general population?
Sicker, mostly because of the designated medically underserved requirement of the health centers because they are in areas where people haven’t had access to care or are marginalized by their situation in public housing or they are homeless or they are a migrant farm worker or just somebody who doesn’t have health insurance and probably hasn’t had health insurance their whole life so they are on the whole a sicker population and have other greater socioeconomic and social determinant factors going into their healthcare besides their access to insurance which is also very important. This needs to be considered as it straps health centers with a lot of burden and responsibility, and I think plays a very important role in our country’s health care system.
Have you found disparities across the country in the patients being served by federally qualified health centers?
Certainly, in different states, it looks very different. In certain states, especially North Carolina, there is a large migrant farm population. In Southern California, that would be the same. So, even in the same state these health centers might vary a lot depending on what the patients need and what sort of programs they are running. In terms of access, we compare Medicaid expansion states and non-Medicaid expansion states and did various tests to see how health centers were different in different resource settings. And they are and their budgets are different and there’s a bigger proportion of HRSA programs in states that more resourced and have greater access to care and some of those states that have more health centers for people who don’t have health insurance.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More